SCHEMBL2854656

SCHEMBL2854656

CCOC(=O)OC1CCC(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
SOAT1 P35610 1/20 0.40
CYP2D6 P10635 1/20 0.38
KMT2A Q03164 2/20 0.35
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
EPHX1 P07099 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1078049 0.86 ALDH1A1 (0.57) ALDH1A1SOAT1EPHX1HSD17B10GAA
SCHEMBL4640870 0.86
SCHEMBL8375449 0.80 ALDH1A1 (0.50) ALDH1A1SOAT1CYP2C19EPHX1HSD17B10
SCHEMBL305155 0.80 ALDH1A1 (0.50) ALDH1A1SOAT1CYP2D6KMT2ACYP2C19
SCHEMBL11591733 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1
SCHEMBL3110206 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1
SCHEMBL11593452 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1
SCHEMBL4630680 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1
SCHEMBL304231 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1
SCHEMBL11592822 0.79 EPHX1 (0.53) ALDH1A1SOAT1KMT2ACYP2C19EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846402-B1 3-AMINO-PYRAZOLO[3,4B]PYRIDINES USED AS INHIBITORS OF PROTEIN TYROSINE KINASES FOR TREATING ANGIOGENIC, HYPERPROLIFERATIVE OR NEURODEGENERATIVE DISEASES BAYER IP GMBH (DE) 2014-02-26 EP disclosed
EP-1758949-B1 POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP AND SULFONIC ACID GROUP, AND PRODUCTION METHOD THEREOF CANON KK (JP) 2010-01-13 EP disclosed
EP-2018387-A1 THIAZOLYLDIHYDROINDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-28 EP disclosed
US-7465779-B2 Polyhydroxyalkanoate having vinyl group, ester group, carboxyl group and sulfonic acid group, and production method thereof CANON KABUSHIKI KAISHA (JP) 2008-12-16 US disclosed
EP-1846402-A1 3-AMINO-PYRAZOLO[3,4B]PYRIDINES USED AS INHIBITORS OF PROTEIN TYROSINE KINASES FOR TREATING ANGIOGENIC, HYPERPROLIFERATIVE OR NEURODEGENERATIVE DISEASES Bayer Schering Pharma Aktiengesellschaft (DE) 2007-10-24 EP disclosed
WO-2007115933-A1 THIAZOLYLDIHYDROINDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-18 WO disclosed
EP-1758949-A2 POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP AND SULFONIC ACID GROUP, AND PRODUCTION METHOD THEREOF Canon Kabushiki Kaisha (JP) 2007-03-07 EP disclosed
US-20060247414-A1 Polyhydroxyalkanoate having vinyl group, ester group, carboxyl group and sulfonic acid group, and production method thereof CANON KABUSHIKI KAISHA (JP) 2006-11-02 US disclosed
WO-2006063805-A1 3-AMINO-PYRAZOLO[3,4B]PYRIDINES USED AS INHIBITORS OF PROTEIN TYROSINE KINASES FOR TREATING ANGIOGENIC, HYPERPROLIFERATIVE OR NEURODEGENERATIVE DISEASES BAYER SCHERING PHARMA AKTINGESELLSCHAFT (DE) 2006-06-22 WO disclosed
WO-2005121206-A2 POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP AND SULFONIC ACID GROUP, AND PRODUCTION METHOD THEREOF CANON KABUSHIKI KAISHA (JP) 2005-12-22 WO disclosed